US 7314887
Thrombopoietin activity modulating compounds and methods
granted A61PA61P21/04A61P25/00
Quick answer
US patent 7314887 (Thrombopoietin activity modulating compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P21/04, A61P25/00, A61P43/00, A61P7/00